Adjuvant chemotherapy for stage III colon cancer: Do physicians agree about the importance of patient age and comorbidity?

Journal of Clinical Oncology

Volumn 26, Issue 15, 2008, Pages 2532-2537

  Keating, Nancy L ^a   Landrum, Mary Beth ^a   Klabunde, Carrie N ^a   Fletcher, Robert H ^a   Rogers, Selwyn O ^a   Doucette, William R ^a   Tisnado, Diana ^a   Clauser, Steven ^a   Kahn, Katherine L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGING; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; CONGESTIVE HEART FAILURE; FEMALE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; AGE; AGED; CANCER STAGING; COLON TUMOR; DECISION MAKING; LUNG TUMOR; MIDDLE AGED; PHYSICIAN; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMORBIDITY; DECISION MAKING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIANS;

EID: 45149119933     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.9434     Document Type: Article

References (32)

1. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
2. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345:939-944, 1995
3. Wolmark N, Rockette H, Mamounas E, et al: Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17:3553-3559, 1999
4. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004
5. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al: Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24:4085-4091, 2006
6. De Gramont A, Boni C, Navarro M, et al: Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow up of six years. J Clin Oncol 25:2007 (abstr 4007)
7. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097, 2001
8. Iwashyna TJ, Lamont EB: Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992-3998, 2002
9. Sundararajan V, Mitra N, Jacobson JS, et al: Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 136:349-357, 2002
10. Jessup JM, Stewart A, Greene FL, et al: Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentiation. JAMA 294:2703-2711, 2005
11. Potosky AL, Harlan LC, Kaplan RS, et al: Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20:1192-1202, 2002
12. Schrag D, Cramer LD, Bach PB, et al: Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93:850-857, 2001
13. Keating NL, Landrum MB, Meara EM, et al: Do increases in managed care market share influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 97:257-264, 2005
14. Cronin DP, Harlan LC, Potosky AL, et al: Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101:2308-2318, 2006
15. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al: Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293-1300, 2003
16. Sargent DJ, Wieand HS, Haller DG, et al: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23:8664-8670, 2005
17. National Center for Health Statistics: Life expectancy tables. http://www.cdc.gov/nchs/fastats/lifexpec.htm
18. Gross CP, McAvay GJ, Krumholz HM, et al: The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: Implications for screening. Ann Intern Med 145:646-653, 2006
19. Ayanian JZ, Chrischilles EA, Fletcher RH, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
20. National Cancer Institute: Cancer Care Outcomes Research and Surveillance Consortium. http://healthservices.cancer.gov/cancors/
21. Little RJ: Statistical Analysis with Missing Data. New York, NY, Wiley, 1986
22. He Y, Zaslavsky AM, Harrington DP, et al: Imputation in a multiformat and multiwave survey of cancer care. Proceedings in Health Policy Statistics, American Statistical Association, 2007
23. Zeger SL, Liang K: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
24. Little RJ: Direct standardization: A tool for teaching linear models for unbalanced data. Am Statistician 36:38-43, 1982
25. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: Colon cancer. http://www.nccn.org/professionals/physician_gls/PDF/ colon.pdf
26. Gross CP, McAvay GJ, Guo Z, et al: The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109:2410-2419, 2007
27. Aapro MS, Kohne CH, Cohen HJ, et al: Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 10:198-204, 2005
28. Extermann M, Bonetti M, Sledge GW, et al: MAX2-a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 40:1193-1198, 2004
29. Choudhry NK, Fletcher RH, Soumerai SB: Systematic review: The relationship between clinical experience and quality of health care. Ann Intern Med 142:260-273, 2005
30. Newman EA, Guest AB, Helvie MA, et al: Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107:2346-2351, 2006
31. Peabody JW, Luck J, Glassman P, et al: Measuring the quality of physician practice by using clinical vignettes: A prospective validation study. Ann Intern Med 141:771-780, 2004
32. Sanoff HK, Bleiberg H, Goldberg RM: Managing older patients with colorectal cancer. J Clin Oncol 25:1891-1897, 2007